Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Doseology Sciences Buyback Yield % Historical Data
* Premium members only.
The historical data trend for Doseology Sciences's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:VU70 vs VRTX, REGN, ALNY: Buyback Yield % Comparison
For the Biotechnology subindustry, Doseology Sciences's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Doseology Sciences Buyback Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Doseology Sciences's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Doseology Sciences's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Doseology Sciences (FRA:VU70) has a Buyback Yield % of 0.00 as of Jul. 23, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Doseology Sciences and its competitors. According to the industry distribution chart, Doseology Sciences ranks #999999 out of 739 companies in the Biotechnology industry.
Is Doseology Sciences' Buyback Yield % too high?
Doseology Sciences' current Buyback Yield % is 0.00. Based on the distribution chart, Doseology Sciences ranks #999999 out of 739 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Doseology Sciences has a GF Score™ of 36/100, reflecting its overall financial health beyond just this single metric.
How does Doseology Sciences' Buyback Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Doseology Sciences ranks #999999 out of 739 companies for Buyback Yield %. This places Doseology Sciences in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Biotechnology company?
A good Buyback Yield % depends on the Biotechnology industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Doseology Sciences and its competitors. Doseology Sciences's current Buyback Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Doseology Sciences stock overvalued right now?
Doseology Sciences (FRA:VU70) has a current Buyback Yield % of 0.00. The stock's GF Value™ is €0.10, compared to a current price of €0.06 — trading 36.5% below its estimated fair value. The current Buyback Yield % is 0.00. Doseology Sciences' overall GF Score™ is 36/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Doseology Sciences (FRA:VU70), the current Buyback Yield % is 0.00 as of Jul. 23, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Doseology Sciences (FRA:VU70) Overvalued in 2026?
Based on GuruFocus' analysis, Doseology Sciences stock appears to be undervalued.
The current stock price of €0.06 is trading 36.5% below its estimated GF Value™ of €0.10.
Key valuation signals for FRA:VU70:
Buyback Yield %: 0.00
GF Value™: €0.10 vs. price of €0.06 (36.5% below fair value)
No single metric tells the full story. See the FRA:VU70 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Doseology Sciences Inc is a diversified life sciences company, on a mission to reimagine mental health therapies through innovation, technology and sustainability. With a focus on the psychedelic and non-psychedelic compounds, also sale of its branded functional mushroom products. It offers cutting-edge therapeutic products and services, with the focus of making a meaningful impact on the mental health pandemic and improving overall health. Geographically earns it revenue from Canada.
36GF Score
Get the complete analysis for FRA:VU70
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:VU70 has been successfully added to your 
